Short Bowel Syndrome and Teduglutide Versus Placebo

NCT02099084 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Short Bowel Syndrome

Interventions

DRUG: Teduglutide
DRUG: Placebo

Sponsor

Mayo Clinic